- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
c-RET antibody recognizes MEN2-associated RET protein, a receptor tyrosine kinase implicated in multiple endocrine neoplasia type 2. Germline activating mutations in the RET gene drive constitutive kinase activation, leading to medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia characteristic of MEN2 syndromes. RET signaling activates MAPK and PI3K-AKT pathways that promote cellular proliferation and survival.
MEN2-associated RET protein mutations frequently occur within the extracellular cysteine-rich domain or intracellular kinase domain, resulting in ligand-independent receptor activation. In addition to hereditary syndromes, somatic RET alterations are observed in sporadic thyroid and lung cancers. Physiologically, RET contributes to neural crest cell migration, kidney development, and neuronal differentiation.
c-RET antibody is suitable for detecting MEN2-associated RET protein in cancer research and studies of endocrine tumor biology. Analysis of RET expression supports investigation of oncogenic kinase activation and therapeutic targeting strategies in RET-driven malignancies.
Optimal dilution of the c-RET/MEN2-Associated RET Protein antibody should be determined by the researcher.
A recombinant partial protein (within amino acids 702-848) from the human protein was used as the immunogen for the c-RET/MEN2-Associated RET Protein antibody.
Aliquot the c-RET/MEN2-Associated RET Protein antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.